Hypocalcemia with osteoblastic metastases in a patient with prostate carcinoma. A cause of secondary hyperparathyroidism

Robert C. Smallridge, H. Linton Wray, Marcus Schaaf

Research output: Contribution to journalArticlepeer-review

32 Scopus citations


A 68 year old man with prostatic carcinoma and extensive painful osteoblastic metastases was discovered to have hypocalcemia (serum calcium 7.1 mg/dl) without evidence of hypoalbuminemia, renal failure or malabsorption. Baseline studies revealed hypocalciuria (24 hour urine calcium <5 mg/day), normal serum phosphate (3.4 mg/dl), low tubular reabsorption of phosphate (68 percent), undetectable serum calcitonin, normal serum 25-hydroxyvitamin D, slightly elevated serum parathyroid hormone level and increased urinary cyclic AMP (8.87 μmol/g creatinine). These studies were compatible with secondary hyperparathyroidism. The intravenous administration of parathyroid extract produced no further change in urinary phosphate but a 25-fold increase in nephrogenous cyclic AMP. Three days administration of intramuscular parathyroid extract slowly and temporarily restored serum calcium to normal levels while increasing urinary cyclic AMP and phosphate. Chemotherapy with cyclophosphamide and 5-fluorouracil rendered the patient free of pain while reducing serum acid and alkaline phosphatase levels and restoring serum total and ionized calcium and urinary cyclic AMP excretion to normal.

Original languageEnglish (US)
Pages (from-to)184-188
Number of pages5
JournalThe American Journal of Medicine
Issue number1
StatePublished - Jul 1981

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Hypocalcemia with osteoblastic metastases in a patient with prostate carcinoma. A cause of secondary hyperparathyroidism'. Together they form a unique fingerprint.

Cite this